Neurology Articles

Neurology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Cormac I et al. – Abrupt cessation of smoking is associated with a potentially serious risk of toxicity in patients taking clozapine. Plasma clozapine levels must be monitored closely and adjustments made in dosage, if necessary, for at least six months after cessation.

Related Articles

A translational research approach to poor treatment response in patients with schizophrenia: clozapine-antipsychotic polypharmacy
Journal of Psychiatry & Neuroscience, 11/11/09    Relevance Score: 89%

Effects of clozapine and olanzapine on cortical thickness in childhood-onset schizophrenia
Schizophrenia Research, 11/17/09    Relevance Score: 84%

In vitro and in vivo evaluation of the inhibition potential of risperidone toward clozapine biotransformation
British Journal of Clinical Pharmacology, 11/05/09    Relevance Score: 82%

Olanzapine-Induced Clinical Seizure: A Case Report
Clinical Neuropharmacology, 10/13/09    Relevance Score: 80%

Today in Neuro/Psych pharmacology...keeping you current

Probable levetiracetam-associated depression in the elderly: Two case reports
The American Journal of Geriatric Pharmacotherapy, 12/18/09

Treatment retention with risperidone long-acting injection: 24-month results from the Electronic Schizophrenia Treatment Adherence Registry in six countries
Current Medical Research and Opinion, 12/18/09

Berberine: a plant alkaloid with therapeutic potential for central nervous system disorders
Phytotherapy Research, 12/18/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address